| PACKAGING TYPE: | 1.5g C-box |
| COMPOSITION: | Cefoperazone 1g+ Sulbactum 500 Mg |
| FORMULATION: | Injection |
| Description: | CEFTICAT S 1.5 gm Injection is a combination of Cefoperazone (1 g) and Sulbactam (500 mg). It is a broad-spectrum beta-lactam/beta-lactamase inhibitor antibiotic used for the treatment of a wide range of moderate to severe bacterial infections. Cefoperazone acts by inhibiting bacterial cell wall synthesis, while Sulbactam enhances its effectiveness by inhibiting beta-lactamase enzymes produced by resistant bacteria. It is commonly used in respiratory tract infections, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, septicemia, and hospital-acquired infections. |
| Side Effects: | Diarrhea or gastrointestinal upset Nausea or vomiting Rash or allergic reactions Injection site pain Liver enzyme elevation (rare) Bleeding tendency (rare, with prolonged use) |
| How to Use: | To be administered only by healthcare professionals Given via intravenous (IV) or intramuscular (IM) route as prescribed Dosage depends on infection severity and patient condition Reconstitution should be done as per standard medical guidelines |
| Precaution: | For hospital use only Use cautiously in patients with penicillin/cephalosporin allergy Monitor liver function during prolonged therapy Dose adjustment may be required in severe hepatic impairment Avoid alcohol during treatment (disulfiram-like reaction risk) |
| Product Benefits: | Broad-spectrum antibiotic coverage Effective against beta-lactamase producing resistant bacteria Useful in severe and hospital-acquired infections Rapid bactericidal action Suitable for ICU and critical care use Strong combination therapy for complic |
Frequently Asked Questions
It is used for serious bacterial infections including respiratory, urinary, and systemic infections.
It prevents bacterial resistance by inhibiting beta-lactamase enzymes.
Yes, it is commonly used in ICU and hospital-acquired infections.










